Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network. With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.
Here, you can go directly to the respective years of Investor Relations News:
19. Juni 2019 | creditshelf cooperates with finleap and plans to extend its activities through the acquisition of Valendo GmbH via capital increase by means of contribution in kind in creditshelf Aktiengesellschaft
Frankfurt am Main/ Berlin, 19 June 2019 – creditshelf Aktiengesellschaft, a pioneer in the field of digital SME financing in Germany, has laid the foundation for a cooperation with finleap, Europe’s leading fintech ecosystem. With today’s signing of a legally nonbinding letter of intent, creditshelf envisages the acquisition of Valendo GmbH, a specialist of technology-based secured financing for small and medium sized companies (SMEs) from the finleap portfolio. This acquisition allows creditshelf to extend its financing options and risk analysis tools with smart secured financing solutions, while Valendo has significant growth potential under the roof of creditshelf.
7 June 2019 | DEAG to acquire majority stake in one of germany’s largest electronic music promoters I-Motion GmbH
Berlin, 7 June 2019 - DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, ISIN: DE000A0Z23G6, Ticker: ERMK, listed in the Prime Standard, today announced that the company is acquiring a majority interest of 50.1% in I-Motion GmbH, the German operating unit of LiveStyle, Inc., USA.
06. Juni 2019 | Dermapharm Holding SE acquires a stake in fitvia
Grünwald, June 06, 2019 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany with a growing international presence, via Dermapharm AG is expanding the group to include a majority stake in the area of healthy nutrition. Dermapharm concluded an agreement to acquire an interest in fitvia GmbH, headquartered in Wiesbaden, Germany, today. With closing of the transaction, Dermapharm AG is acquiring 70.00 percent of the shares in the company specialized in healthy nutrition. The purchase agreement is still subject to the approval of the antitrust authority. The Management Board expects the transaction to be completed in the third quarter of 2019.
June 4, 2019 | Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.77 per share
Management Board and Supervisory Board discharged by large majority
Fiscal year 2018 marked by introduction of self-developed products, further internationalization and successful acquisitions
Continuation of profitable growth course in 2019